Skip to main content
Medical information Clinical review pending

Genetic Testing

APOC2 Gene Apolipoprotein CII Deficiency Genetic Test

Genetic test to identify mutations in the APOC2 gene, associated with Apolipoprotein C-II deficiency and lipid metabolism disorders. Helps assess risk and inform management.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood, Extracted DNA, or One drop of blood on FTA Card.
Results
Confirm with the laboratory before booking.
Preparation
Provide clinical history. A genetic counseling session to draw a pedigree chart of affected family members is recommended before testing. Confirm with the laboratory before booking.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the APOC2 Gene Apolipoprotein CII Deficiency Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Symptoms of lipid metabolism disorders
  • ✓High cholesterol levels
  • ✓Family history of metabolic disorders
  • ✓Family history of Apolipoprotein C-II deficiency
  • ✓Symptoms of pancreatitis
  • ✓Symptoms of cardiovascular issues
02

In plain language

What this test helps you understand

Identifies genetic mutations in the APOC2 gene associated with Apolipoprotein C-II deficiency, aiding in the diagnosis and management of lipid metabolism disorders.
The APOC2 Gene Apolipoprotein CII Deficiency NGS Genetic DNA Test is an advanced diagnostic tool used to identify genetic mutations linked to Apolipoprotein C-II deficiency. This condition can lead to significant metabolic disorders affecting lipid metabolism. Using Next Generation Sequencing (NGS) technology, this test offers a detailed analysis of the APOC2 gene. Early detection through this test allows for better management of lipid metabolism disorders. This test measures variations within the APOC2 gene, which is crucial for regulating lipid metabolism. Detecting mutations can help healthcare providers understand an individual's risk for conditions like hyperlipidemia. This test is recommended for individuals experiencing symptoms related to lipid metabolism issues, such as high cholesterol levels, or those with a family history of metabolic disorders, pancreatitis, or cardiovascular problems. A family history of Apolipoprotein C-II deficiency is also a key indicator for considering this test. Taking this test provides several benefits, including early identification of genetic risks for metabolic disorders, enabling informed decisions about lifestyle and treatment. It also offers valuable information for family planning and genetic counseling. Understanding your results involves interpreting whether mutations in the APOC2 gene were found. A genetic counseling session is highly recommended to discuss the implications of the results for you and your family. It's important to note that a positive result indicates an increased risk, not a guaranteed development of a disorder, and may warrant further monitoring.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationProvide clinical history. A genetic counseling session to draw a pedigree chart of affected family members is recommended before testing. Confirm with the laboratory before booking.
SampleBlood, Extracted DNA, or One drop of blood on FTA Card.
MethodologyNext Generation Sequencing (NGS) analysis of the APOC2 gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects specific mutations in the APOC2 gene. It may not detect all possible mutations. A positive result indicates increased risk, not certainty of disease development. Genetic counseling is recommended for interpretation.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Apolipoprotein C-II deficiency is a genetic disorder affecting lipid metabolism, potentially leading to high triglyceride levels and pancreatitis.
Individuals with symptoms of lipid metabolism disorders, high cholesterol, or a family history of related conditions should consider this test.
The test involves analyzing a sample of your blood, extracted DNA, or a blood spot on an FTA card for specific mutations in the APOC2 gene.
Results indicate the presence or absence of specific APOC2 gene mutations. Genetic counseling is recommended to understand the implications.
Genetic counseling is recommended for interpreting results but may be arranged separately. Confirm with the laboratory before booking.
A positive result indicates an increased risk for Apolipoprotein C-II deficiency or related conditions. Further medical evaluation and monitoring may be needed.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp